Biogen Idec (NASDAQ:BIIB) is a biotechnology company that makes drugs to treat cancer, neurological diseases, and autoimmune diseases. The company's most important products are Avonex and Rituxan, which treat multiple sclerosis (MS) and non-Hodgkin's lymphomas (NHLs), respectively. The company...
accounting analysis
advansourcebiomaterials
annual statement
balance sheet
business finance
business valuation
debt instruments
finance companies
financial analysis
financial analysis report
financial analysts
financial ratio
financial statement
fundamental analysis
funds management
hedge funds
income statement
mutual funds
net income
p&l account
personal finance
private equity
public finance
return on equity
us company finance
